Form 4: Astrana Health Director Linda Marsh Reports Acquisition of Restricted Stock

Director Linda Marsh reports acquisition of 3,564 shares of Astrana Health restricted stock, vesting on the earlier of August 13, 2025, or the 2025 annual meeting.

Summary

• On August 13, 2024, Linda Marsh, a director of Astrana Health, Inc., acquired 3,564 shares of common stock.
• These shares were granted as restricted stock under the company's 2024 Equity Incentive Plan.
• The restricted shares will vest on the earlier of August 13, 2025, or the date of the company's 2025 annual meeting of stockholders.
• Following the transaction, Marsh beneficially owns 69,714 shares of Astrana Health, Inc.
• Marsh has granted power of attorney to Brandon Sim, Chandan Basho, John Vong, and Kathy Diep to handle SEC filings on her behalf.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director, which doesn't inherently indicate positive or negative sentiment.

Positives

• The acquisition of restricted stock by a director could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The restricted shares will vest on the earlier of August 13, 2025, or the date of the Issuer's 2025 annual meeting of stockholders.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency regarding the holdings and transactions of company insiders.

Key Dates